Cargando…
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
Therapeutic alteration of gene expression in vivo can be achieved by delivering nucleic acids (e.g., mRNA, siRNA) using nanoparticles. Recent progress in modified messenger RNA (mmRNA) synthesis facilitated the development of lipid nanoparticles (LNPs) loaded with mmRNA as a promising tool for in vi...
Autores principales: | Veiga, Nuphar, Goldsmith, Meir, Granot, Yasmin, Rosenblum, Daniel, Dammes, Niels, Kedmi, Ranit, Ramishetti, Srinivas, Peer, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206083/ https://www.ncbi.nlm.nih.gov/pubmed/30374059 http://dx.doi.org/10.1038/s41467-018-06936-1 |
Ejemplares similares
-
Conformation Sensitive Targeting of Lipid Nanoparticles for RNA Therapeutics
por: Dammes, Niels, et al.
Publicado: (2021) -
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
por: Rosenblum, Daniel, et al.
Publicado: (2020) -
Lipid nanoparticles-loaded with toxin mRNA represents a new strategy for the treatment of solid tumors
por: Granot-Matok, Yasmin, et al.
Publicado: (2023) -
A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery
por: Naidu, Gonna Somu, et al.
Publicado: (2023) -
Paving the Road for RNA Therapeutics
por: Dammes, Niels, et al.
Publicado: (2020)